Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytopenia”

1,638 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,638 results

Testing effectiveness (Phase 2)Looking for participantsNCT06599762
What this trial is testing

Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid LeukemiaMyelodysplastic/Myeloproliferative Neoplasm
University of Manitoba 75
Testing effectiveness (Phase 2)Study completedNCT01890746
What this trial is testing

A Safety and Efficacy Study of Eltrombopag in Subjects With AML

Who this might be right for
Acute Leukaemia
Novartis Pharmaceuticals 148
Not applicableStudy completedNCT00020527
What this trial is testing

Caspofungin Acetate in Treating Children With Fever and Neutropenia

Who this might be right for
Fever, Sweats, and Hot FlashesInfectionKidney Cancer+5 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT05805202
What this trial is testing

Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized Therapy

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Mario Negri Institute for Pharmacological Research 112
Testing effectiveness (Phase 2)UnknownNCT06190145
What this trial is testing

Teriflunomide for Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 40
Not applicableUnknownNCT03198195
What this trial is testing

Post-transplant Cyclophosphamide in Wiskott-Aldrich Syndrome

Who this might be right for
Wiskott-Aldrich Syndrome
Capital Research Institute of Pediatrics 5
Testing effectiveness (Phase 2)Ended earlyNCT00673439
What this trial is testing

Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-Induced Thrombocytopenia
University of Louisville 3
Testing effectiveness (Phase 2)Study completedNCT03395210
What this trial is testing

Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Principia Biopharma, a Sanofi Company 86
Post-approval studies (Phase 4)Not Yet RecruitingNCT07320534
What this trial is testing

Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase

Who this might be right for
Neutropenic FeverAcute Lymphoblastic Leukemia
Gadjah Mada University 124
Large-scale testing (Phase 3)Ended earlyNCT00806351
What this trial is testing

An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System

Who this might be right for
FungemiaNeutropeniaCandidiasis
Pfizer 21
Large-scale testing (Phase 3)Study completedNCT03252431
What this trial is testing

Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Who this might be right for
Breast CancerNeutropenia
EVIVE Biotechnology 393
Testing effectiveness (Phase 2)Ended earlyNCT05086744
What this trial is testing

Basket Study to Assess Efficacy, Safety and PK of Iptacopan (LNP023) in Autoimmune Benign Hematological Disorders

Who this might be right for
Immune Thrombocytopenia (ITP)Cold Agglutinin Disease (CAD)
Novartis Pharmaceuticals 19
Large-scale testing (Phase 3)Not Yet RecruitingNCT07597395
What this trial is testing

ATRA for Management of Primary ITP

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 192
Not applicableLooking for participantsNCT04745195
What this trial is testing

Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium

Who this might be right for
Thrombotic MicroangiopathiesHemolytic Uremic Syndrome, AtypicalHemolytic-Uremic Syndrome
Maastricht University Medical Center 42
Very early researchNot Yet RecruitingNCT07696767
What this trial is testing

Efficacy and Safety of MegaLT Injection for Platelet Recovery After Umbilical Cord Blood Transplantation

Who this might be right for
ThrombocytopeniaHematologic MalignaciesPlatelet Recovery After Umbilical Cord Blood Transplantation
Anhui Provincial Hospital 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT07733037
What this trial is testing

Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Peking University People's Hospital 42
Testing effectiveness (Phase 2)WithdrawnNCT01194167
What this trial is testing

Study of Eltrombopag in Platelet Refractory Thrombocytopenia

Who this might be right for
Thrombocytopenia
University of Cincinnati
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07603557
What this trial is testing

Study of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE)

Who this might be right for
Chronic Immune ThrombocytopeniaAutoimmune Hemolytic Anemia
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 52
Not applicableActive Not RecruitingNCT05396157
What this trial is testing

Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study

Who this might be right for
Thrombosis, VenousBleeding HemorrhageVenous Thromboembolic Disease+2 more
Mount Sinai Hospital, Canada 813
Testing effectiveness (Phase 2)Looking for participantsNCT07234019
What this trial is testing

Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 160
Next Page